Please login or register first to view this content.
Dermatological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
FDA Approval Allows for Use of Dupixent Prefilled Pens in Younger Patients
Ruxolitinib Cream Results in Greater Repigmentation in Vitiligo
September 2022 Recap: Drug Pipeline Updates
September 2022: Notable Drug Approvals
IV Immune Globulin Bests Placebo for Dermatomyositis
ACR Updating Guideline for Glucocorticoid-Induced Osteoporosis
Vaccine-Associated Aluminum Linked to Persistent Asthma in Young Children
Dupixent Approved for Adults With Prurigo Nodularis
Roflumilast Foam Effective for Scalp, Body Psoriasis in Phase 3 Trial
Multidose Antibiotic Prophylaxis No Better for Breast Implant Surgery
First Generic Versions of Tazorac Gel Get FDA Approval
Dupilumab Eases Atopic Dermatitis in Children Younger Than 6 Years
Cemiplimab Studied as Neoadjuvant Therapy for Cutaneous SCC
FDA Approves Sotyktu for Moderate to Severe Plaque Psoriasis
FDA to Review Ritlecitinib for Alopecia Areata
August 2022 Recap: Drug Pipeline Update
Spevigo Approved to Treat Generalized Pustular Psoriasis Flares
Hyftor Topical Gel Now Available for TSC-Associated Facial Angiofibroma
